Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2021-04-06 08:45:00
The Board of Directors in SoftOx Solutions AS (the "Company") approved the 2020
annual financial statements prepared in accordance with Norwegian Accounting Act
and accounting standards and practises generally accepted in Norway.
The financial statements are in accordance with the Q4 reporting published
on 9th February 2021.
The annual report 2020 will be made available on SoftOx Solutuions AS's
website www.soft-ox.com on 6 April 2021. SoftOx Solutions AS's annual general
meeting is planned to be held on 13 April 2021.
For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Kristine Rød, Finance Manager in SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599
About SoftOx Solutions AS
SoftOx Solutions AS is a Norwegian BioTech company listed on Euronext Growth
Oslo. Our Vison is "Helping the world fighting infections - developing new ways
of eradicating infections and fighting antimicrobial resistance". We are working
to combat major threats to human health, namely the emergence of antimicrobial
resistance (AMR), biofilm infections in chronic wounds and the spread of
viruses. For more information on SoftOx, visit www.soft-ox.com